The changing face of percutaneous image-guided biopsy: Molecular profiling and genomic analysis in current practice

Journal of Vascular and Interventional Radiology

Volumn 24, Issue 8, 2013, Pages 1094-1103

  Marshall, Dustyn ^a   Laberge, Jeanne M ^a   Firetag, Brandie ^a   Miller, Theodore ^a   Kerlan, Robert K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERLOTINIB; ESTROGEN RECEPTOR; FLUOROURACIL; GEFITINIB; GLYPICAN 3; K RAS PROTEIN; LAPATINIB; MUCIN; PERTUZUMAB; PROGESTERONE RECEPTOR; PROTEIN P53; PROTEIN TYROSINE KINASE INHIBITOR; SORAFENIB; TAMOXIFEN; TRASTUZUMAB; TUMOR MARKER; VEMURAFENIB;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER PALLIATIVE THERAPY; CELL SHAPE; CELL STRUCTURE; CHEMOEMBOLIZATION; CHROMOSOME; COLON ADENOCARCINOMA; COLORECTAL CANCER; CYTOLOGY; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; DNA DENATURATION; DNA SEQUENCE; ENDOSCOPIC BIOPSY; FALSE NEGATIVE RESULT; FINE NEEDLE ASPIRATION BIOPSY; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GENE SEQUENCE; GENETIC DISORDER; GENETIC SCREENING; GENOME ANALYSIS; GIEMSA STAIN; HISTOPATHOLOGY; HUMAN; IMAGE GUIDED BIOPSY; IMMUNOHISTOCHEMISTRY; INTERVENTIONAL RADIOLOGY; KIDNEY CARCINOMA; LARGE CORE NEEDLE BIOPSY; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MELANOMA; METASTATIC MELANOMA; MICROSATELLITE INSTABILITY; MITOSIS RATE; MOLECULAR BIOLOGY; ONCOGENE RAS; PANCREAS ADENOCARCINOMA; PAPANICOLAOU TEST; PERCUTANEOUS BIOPSY; PERCUTANEOUS IMAGE GUIDED BIOPSY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIOLOGIST; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR GENE; TUMOR SUPPRESSOR GENE;

EGFR; EPIDERMAL GROWTH FACTOR RECEPTOR; FINE-NEEDLE ASPIRATION; FISH; FLUORESCENCE IN SITU HYBRIDIZATION; FNA; H&E; HCC; HEMATOXYLIN AND EOSIN; HEPATOCELLULAR CARCINOMA; IHC; IMMUNOHISTOCHEMISTRY; MISMATCH REPAIR; MMR; NON-SMALL-CELL LUNG CANCER; NSCLC; PCR; POLYMERASE CHAIN REACTION; RCC; RENAL CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOMICS; HUMANS; IMAGE-GUIDED BIOPSY; INDIVIDUALIZED MEDICINE; MEDICAL ONCOLOGY; MOLECULAR TARGETED THERAPY; NEOPLASMS; PATIENT SELECTION; PHENOTYPE; PREDICTIVE VALUE OF TESTS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84880731908     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2013.04.027     Document Type: Review

References (41)

1. S.W. Kwan, M. Bhargavan, R.K. Kerlan Jr, and J.H. Sunshine Effect of advanced imaging technology on how biopsies are done and who does them Radiology 256 2010 751 758
2. G.S. Gazelle, and J.R. Haaga Guided percutaneous biopsy of intraabdominal lesions Am J Radiol 153 1989 929 935
3. S. Gupta, M.J. Wallace, J.F. Cardella, S. Kundu, D.L. Miller, S.C. Rose Society of Interventional Radiology Standards of Practice Committee Quality improvement guidelines for percutaneous needle biopsy J Vasc Interv Radiol 21 2010 969 975
4. C. Chung, and M. Christianson Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: a systemic review of current development, evidence, and recommendation J Oncol Pharmacy Pract 2013 Mar 14 [Epub ahead of print]
5. C.J. Stewart, J. Coldewey, and I.S. Stewart Comparison of fine needle aspiration cytology and needle core biopsy in the diagnosis of radiologically detected abdominal lesions J Clin Pathol 55 2002 93 97
6. K.D. McClatchy Clinical Laboratory Medicine 2nd ed 2002 Lippincott Williams & Wilkins Philadelphia, PA
7. D.J. Dabbs Diagnostic Immunohistchemistry: Therangostic and Genomic Applications 3rd ed 2010 Saunders Philadelphia, PA
8. R. Sigel, N. Deepa, and J. Ahmedin Cancer statistics, 2013 CA Cancer J Clinicians 63 2013 11 30
9. G.M. Clark, W.L. McGuire, C.A. Hubay, O.H. Pearson, and J.S. Marshall Progesterone receptors as a prognostic factor in stage II breast cancer N Engl J Med 309 1983 1343
10. A.K. Tandon, G.M. Clark, G.C. Chamness, A. Ullrich, and W.L. McGuire HER-2/neu oncogene protein and prognosis in breast cancer J Clin Oncol 7 1989 1120 1128
11. J. Winston, J. Ramanaryanan, and E. Levine HER-2/neu evaluation in breast cancer: are we there yet Am J Clin Pathol 121 2004 533 549
12. S. Abdul-Rasool, S.H. Kidson, E. Panieri, D. Dent, K. Pillay, and G.S. Hanekom An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes J Clin Pathol 59 2006 289 297
13. M. MacNeill, I. Arnott, and J. Thomas Fine needle aspiration cytology is a valuable adjunct to axillary ultrasound in the preoperative staging of breast cancer J Clin Pathol 64 2011 42 46
14. T. Yano, A. Haro, and Y. Shikada Non-small cell lung cancer in never smokers as a representative non-smoking-associated lung cancer: epidemiology and clinical features Int J Clin Oncol 16 2011 287 293
15. M. Soda, Y.L. Choi, and M. Enomoto Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer Nature 448 2007 561 566
16. S.B. Solomon, M.F. Zakowski, and W. Pao Core needle lung biopsy specimens: adequacy for EGFR and KRAS mutational analysis AJR Am J Roentgenol 194 2010 266 269
17. H.J. Yoon, H.Y. Lee, and K.S. Lee Repeat biopsy for mutational analysis of non-small cell lung cancers resistant to previous chemotherapy: adequacy and complications Radiology 265 2012 939 948
18. J. García-Foncillas, and E. Díaz Rubio Progress in metastatic colorectal cancer: growing role of cetuximab to optimize clinical outcome Clin Transl Oncol 12 2010 533 542
19. J. Laurini, P. Aoun, J. Iqbal, W. Chan, and T.C. Greiner Investigation of the BRAFVV600E mutation by pyrosequencing in lymphoproliferative disorder Am J Clin Pathol 138 2012 877 883
20. V. Deschoolmeester, M. Baay, P. Specenier, F. Lardon, and J.B. Vermorken A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy Oncologist 15 2010 699 731
21. A. Jemal, S. Devesa, P. Hartge, and M. Tucker Recent trends in cutaneous melanoma incidence among whites in the United States J Natl Cancer Inst 93 2001 678 683
22. F. Spagnolo, and P. Queirolo Upcoming strategies for the treatment of metastatic melanoma Arch Dermatol Res 304 2012 177 184
23. J. Zhou, L. Enewold, and A. Stojadinovic Incidence rates of exocrine and endocrine pancreatic cancers in the United States Cancer Causes Control 21 2010 853 861
24. G.A. Zamboni, M. D'Onofrio, and A. Idili Ultrasound-guided percutaneous fine-needle aspiration of 545 focal pancreatic lesions AJR Am J Roentgenol 193 2009 1691 1695
25. B. Bournet, A. Pointreau, and A. Souque Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fine needle aspiration samples Pancreatology 12 2012 27 34
26. S. Ali, C. Cohen, J.V. Little, J.H. Sequeira, M.B. Mosunjac, and M.T. Siddiqui The utility of SMAD4 as a diagnostic immunohistochemical marker for pancreatic adenocarcinoma, and its expression in other solid tumors J Diagn Cytopathol 35 2007 644 648
27. M. Tascilar, G.J. Offerhaus, and R. Altink Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and duct Am J Clin Pathol 116 2001 831 837
28. J.F. Perz, G.L. Armstrong, L.A. Farrington, Y.J. Hutin, and B.P. Bell The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide J Hepatol 45 2006 529
29. K. Yamakado, A. Nakatsuka, and H. Takaki Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy Radiology 247 2008 260 266
30. S. Leoni, F. Piscaglia, and R. Golfieri The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria Am J Gastroenterol 105 2010 599 609
31. D. Jain Diagnosis of hepatocellular carcinoma: fine needle aspiration cytology or needle core biopsy J Clin Gastroenterol 35 2002 101 108
32. A. Wee Fine needle aspiration biopsy of hepatocellular carcinoma and hepatocellular nodular lesions: role, controversies and approach to diagnosis Cytopathology 22 2011 287 305
33. J. Kanitakis, B. Chouvet, A. Claudy, and J.Y. Scoazec Immunoreactivity of hepatocyte paraffin 1 monoclonal antibody in cutaneous metastatic tumors Am J Clin Pathol 122 2004 85 89
34. F. Wang, X. Jing, and T. Want Differential diagnostic value of GPC3-CD34 combined staining in small liver nodules with diameter less than 3 cm Am J Clin Pathol 137 2012 937 945
35. American Urological Association Education and Research, Inc. Guideline for management of the clinical stage 1 renal mass. Linthicum, MD: American Urological Association Education and Research, Inc. 2009
36. H.J. Tan, B.L. Jacobs, and K.S. Hafez Understanding the role of percutaneous biopsy in the management of patients with a small renal mass Urology 79 2012 372 377
37. E.A. Ahmed, and M.E. Youssif Immunohistochemical study of c-kit (CD117) expression in renal cell carcinoma J Egypt Natl Cancer Inst 21 2009 121 132
38. B. Ingold, P.J. Wild, and A. Nocito Renal cell carcinoma marker reliably discriminates central nervous system hemangioblastoma from brain metastases of renal cell carcinoma Histopathology 52 2008 674 678
39. A. Volpe, A. Finelli, and I.S. Gill Rationale for percutaneous biopsy and histologic characterization of renal tumors Eur J Urol 62 2012 491 504
40. I. Millet, F. Curros, I. Serre, P. Taourel, and R. Thuret Can renal biopsy accurately predict histological subtype and Fuhrman grade of renal cell carcinoma? J Urol 188 2012 1690 1694
41. H. El-Osta, D. Hong, and J. Wheler Outcomes of research biopsies in phase I clinical trials: the MD Anderson Cancer Center experience Oncologist 16 2011 1292 1298